PATENT CLAIM ANALYSIS

Application Number: 15950949
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "239500"]

Abstract:
The present invention provides methods for reducing loss of muscle strength, muscle mass, or Type I muscle fibers in an immobilized limb by administering (E)-[4-[3-(4-Fluorophenyl)-3-[4-[3-(morpholin-4-yl)propynyl]phenyl]allyloxy]-2-methyl-phenoxy]acetic acid or a pharmaceutically acceptable salt thereof.

Claim (Index 19):
The method of  claim 15 , wherein:\n the treatment comprises activating PPAR\u03b4 in skeletal muscle in the subject.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 91.0
- Lexical Diversity: 1.34783
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14478594', '15286661', '12810123', '14016442', '15897796']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7677300117176404
- 35 USC 102 Novelty (BERT): 0.5880656481355906
- Combined Prediction Score: 0.7497635753594355
- Mean Citation Score: 360.081022
- Max Citation Score: 534.8824
- Similarity Product: 399.5056529948711

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test